Plain-English translation of NCT06512558 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing an augmented reality system — a new technology that creates a 3D view with virtual transparency of the breast during cancer surgery. The system combines the surgeon's camera feed with preoperative imaging in real time, allowing the surgeon to see exactly where the cancer is located inside the breast.
Currently, surgeons use a painful metal guide inserted under the skin to locate small breast cancers that cannot be felt by hand. This procedure is uncomfortable for patients and requires coordination between two hospital departments. Even with this method, 10–40% of patients need a second surgery because the cancer margins were not completely removed. This trial aims to test whether the new technology can make surgery more precise, less painful, and reduce the need for repeat procedures.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive the standard surgical removal of your breast cancer, but the surgeon will use the new augmented reality system to help locate and remove it. Before surgery, you will have the breast MRI scan that was already recommended for your care. During surgery, the augmented reality system will guide the surgeon in real time. The trial is designed to test whether this new technology works safely and effectively.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
France